- Semaglutide costs range from $199 per month (compounded via telehealth) to over $1,600 per month (brand-name Wegovy without insurance).
- Compounded semaglutide contains the same active ingredient as Wegovy and is prepared by FDA-registered pharmacies using pharmaceutical-grade API.
- Most insurance plans do not cover weight loss medications, making cash-pay compounded options the practical choice for most patients.
- Hidden fees including consultation charges, shipping, syringe kits, and dose-increase fees can add $50 to $300 per month to your real cost.
- Kind MD's all-inclusive pricing covers medication, provider visits, supplies, and shipping with no separate charges.
- The short answer: what semaglutide actually costs
- Brand-name vs. compounded: what you pay and why
- Telehealth provider pricing comparison
- Why brand-name costs so much
- Why compounded costs less
- What factors affect your cost
- Hidden fees to watch for
- Kind MD's transparent all-inclusive pricing
- Cost over time: 3, 6, and 12-month projections
- Frequently asked questions
The short answer: what semaglutide actually costs
Semaglutide costs range from $199 per month for compounded formulations through licensed telehealth providers to over $1,600 per month for brand-name Wegovy without insurance. Most commercially insured patients who do qualify for Wegovy coverage still pay $25 to $500 out of pocket depending on their plan. Medicare does not cover weight loss medications at all.
The price gap between brand-name and compounded semaglutide is not a sign of lower quality. Both contain the same active ingredient. The difference comes from where each travels through the pharmaceutical supply chain before reaching you. Understanding this gap is the first step to making a cost-effective decision for your weight loss treatment.
Brand-name vs. compounded: what you pay and why
There are two primary categories of semaglutide available today. Each has a very different cost structure.
Brand-name semaglutide
Two brand-name semaglutide products are prescribed for weight loss in the United States.
- Wegovy (semaglutide 2.4mg): FDA-approved specifically for chronic weight management. List price approximately $1,349 to $1,600 per month depending on pharmacy and supply availability. Novo Nordisk offers a savings card that may reduce cost to $0 for eligible commercially insured patients, but the program has eligibility restrictions and does not apply to Medicare or Medicaid beneficiaries.
- Ozempic (semaglutide 0.5mg to 2mg): FDA-approved for type 2 diabetes, but widely prescribed off-label for weight loss. List price approximately $935 to $1,000 per month. Insurance coverage is more common than for Wegovy when prescribed for diabetes, but off-label prescriptions for weight management are frequently denied.
Compounded semaglutide
Compounded semaglutide is prepared by FDA-registered compounding pharmacies using pharmaceutical-grade semaglutide API (active pharmaceutical ingredient). These pharmacies operate under 503A or 503B standards and compound to order for individual patients. Because they purchase the API directly and compound it in-house, the cost does not carry the brand manufacturer's markup layers.
Compounded semaglutide via telehealth typically ranges from $199 to $499 per month, depending on the provider, dose, and what is included in the price. At the lower end of this range, you are looking at roughly one-eighth the cost of brand-name Wegovy at list price.
Telehealth provider pricing comparison
The telehealth semaglutide market has expanded rapidly since 2022. Pricing, what is included, and provider quality vary significantly. The table below reflects publicly available pricing data as of April 2026. Always confirm pricing directly with any provider before enrolling, as prices change frequently.
| Provider / Option | Monthly Cost | What Is Included | Dose Range | Best For |
|---|---|---|---|---|
| Wegovy (brand) Novo Nordisk |
$1,349+/mo | Medication only. Consultation and pharmacy fees separate. | 0.25mg to 2.4mg | Commercially insured with coverage. Novo savings card eligible patients. |
| Ozempic (brand, off-label) Novo Nordisk |
$935+/mo | Medication only. Provider visit and pharmacy fees separate. | 0.25mg to 2mg | Type 2 diabetes patients with insurance. Off-label weight loss often denied. |
| Kind MD Compounded telehealth |
From $199/mo | Medication, provider visits, supplies, free expedited shipping. All-inclusive. | 0.25mg to 2.4mg | Cost-conscious patients wanting full-service transparent pricing. |
| Hims & Hers Compounded telehealth |
$199-$299/mo | Medication, provider access. Shipping sometimes extra. Dose adjustments may incur fees. | 0.25mg to 2.4mg | Brand-recognition seekers. Variable plan transparency. |
| Ro Body Compounded telehealth |
$249-$399/mo | Medication, coaching, provider access. Requires annual plan commitment. | 0.25mg to 2.4mg | Patients who want structured coaching with medication. |
| Noom Med Compounded telehealth |
$149-$249/mo | Medication plus Noom app subscription bundled. Separate app fees if discontinued. | 0.25mg to 2mg | Patients already using Noom behavioral coaching platform. |
| Found Compounded telehealth |
$99-$199/mo | Medication. Membership fee required. Lab work extra. Shipping not always included. | 0.25mg to 2mg | Price-sensitive patients comfortable with tiered service model. |
| LifeMD / Shapiro MD Compounded telehealth |
$199-$350/mo | Medication, provider access. Variable on consultation and shipping fees by plan. | 0.25mg to 2.4mg | Patients comfortable with larger corporate telehealth model. |
| Local weight loss clinic In-person provider |
$400-$800/mo | Medication, in-person visits. Significant geographic and cost variability. | 0.25mg to 2.4mg | Patients who prefer in-person care and live near a provider. |
Prices reflect publicly available information as of April 2026. Contact each provider directly for current rates. All costs shown are cash-pay unless noted.
Why brand-name semaglutide costs so much
Wegovy's list price of over $1,300 per month is not arbitrary. It reflects several layers of cost that Novo Nordisk builds into brand pharmaceutical pricing.
Research and development investment
Novo Nordisk spent over $4 billion in R&D costs across the development of the semaglutide molecule and its clinical trial program spanning more than 15 years. The STEP clinical trial program alone enrolled over 4,500 patients across multiple phase 3 studies worldwide. These costs are recovered through brand pricing while the patent remains in force.
Regulatory approval costs
Achieving FDA approval for a new weight management indication requires extensive documentation, inspections, and post-market commitments. Novo Nordisk submitted a New Drug Application with data from eight STEP trials and committed to post-approval safety monitoring programs. These regulatory costs are embedded in the brand price.
Marketing and direct-to-consumer advertising
Novo Nordisk spent an estimated $300 to $400 million on Wegovy direct-to-consumer advertising in 2023 alone. This includes television, digital, and print campaigns driving the brand-name recognition that justifies the premium price point for brand-loyal consumers. These marketing costs are built into every prescription filled.
Shortage premiums and supply constraints
Wegovy faced significant supply shortages from 2022 through 2024 as demand outpaced Novo Nordisk's manufacturing capacity. While supply has improved, the demand curve for GLP-1 medications continues to grow faster than production infrastructure can scale. This demand pressure sustains high pricing with limited competitive pressure from insurance negotiations.
Why compounded semaglutide costs less
The cost difference between compounded and brand semaglutide comes down to where each one enters the supply chain and how many intermediaries take a margin before it reaches you.
No R&D recovery or brand marketing
Compounding pharmacies purchase pharmaceutical-grade semaglutide API that is already manufactured. They pay for the raw material and the compounding process, not the decades of drug development costs that Novo Nordisk incurs. They also do not run national television advertising campaigns. The savings from these omissions pass directly to the patient.
Pharmacy-direct model
Traditional pharmaceutical supply chains run through manufacturers, wholesale distributors, pharmacy benefit managers (PBMs), and retail pharmacies, with each layer taking a margin. Compounding pharmacies prepare medications to order and ship directly to the patient, eliminating multiple margin layers. Telehealth providers coordinate between the pharmacy and the patient without the overhead of a physical clinic network.
Legal foundation for compounding during shortage
From 2022 through 2024, the FDA included both Ozempic and Wegovy on its drug shortage list. During this period, 503A and 503B compounding pharmacies were permitted by federal law to compound semaglutide to meet patient demand. The FDA removed semaglutide from the shortage list in early 2025, and the landscape for compounding continues to evolve based on regulatory guidance. Kind MD works exclusively with pharmacies operating in full compliance with current FDA requirements.
See exactly what you pay with Kind MD before you commit.
No consultation fee. No hidden charges. A licensed provider reviews your intake personally.
Take the Free Quiz →What factors affect your cost
Even within the compounded telehealth category, your actual monthly cost varies based on several variables. Understanding these factors lets you compare providers on a true apples-to-apples basis.
Dose and titration schedule
Semaglutide is started at a low dose (typically 0.25mg weekly) and increased gradually over four to twelve months. Higher doses require more medication per month. Some providers charge different rates for different dose levels. At Kind MD, your price remains fixed regardless of where you are in the titration schedule.
Treatment duration
Most providers offer lower per-month costs when you commit to three-month or six-month plans upfront. Monthly plans offer more flexibility but typically cost more per dose. Understanding the discount structure before committing matters significantly over a 12-month treatment course.
Provider model and visit frequency
Telehealth providers vary in how often they require check-ins and whether those check-ins are included or billed separately. Some providers charge a flat subscription fee and include unlimited messaging. Others bill per visit. In-person clinics typically require monthly appointments at additional cost per visit.
Shipping model
Semaglutide requires refrigerated shipping during transit. Some providers include this in their monthly price. Others charge $15 to $30 per shipment for standard or refrigerated delivery. Over a 12-month course, shipping costs can add $180 to $360 to your total spend if they are not included.
Supply kit components
Injectable semaglutide requires syringes and needles. Some providers include these in their monthly price. Others charge separately or require you to purchase them at a pharmacy. Syringe costs typically run $10 to $25 per month if not included.
Hidden fees to watch for
Advertised starting prices often do not reflect what you will actually pay by month three. These are the most common additional charges to ask about before signing up with any provider.
Always ask: "What is the total all-in monthly cost at the dose I will be on in month six?" That is the number that matters.
Kind MD's transparent all-inclusive pricing
Kind MD was built specifically to solve the hidden-fee problem that makes it impossible to know what you will actually pay. Our pricing is all-inclusive. There is no line-item surprises after the first month.
- Pharmaceutical-grade compounded semaglutide prepared by an FDA-registered 503A pharmacy
- Licensed provider intake evaluation and full prescription (included, not billed separately)
- Ongoing provider access for questions, side effect management, and dose adjustments
- Syringe and needle kit included with every shipment
- Free expedited shipping on every order, including refrigerated transit when required
- Structured dose escalation protocol reviewed personally by a licensed provider
- No monthly membership fee, no platform subscription, no setup charge
Cost over time: 3, 6, and 12-month projections
Most patients pursue semaglutide as a multi-month treatment. The cumulative cost difference between brand-name and compounded options is substantial at the 12-month mark.
| Option | 3 Months | 6 Months | 12 Months | Notes |
|---|---|---|---|---|
| Kind MD (compounded) | $597 | $1,194 | $2,388 | All-inclusive. Price does not increase with dose. |
| Hims / Hers (compounded) | $750 | $1,500 | $3,000 | Shipping extra. Dose adjustments may incur fees. |
| Ro Body (compounded) | $900 | $1,800 | $3,600 | Annual commitment often required for lower rate. |
| Local weight loss clinic | $1,800 | $3,600 | $7,200 | In-person visit fees included in estimate. |
| Wegovy (brand, no insurance) | $4,047 | $8,094 | $16,188 | List price $1,349/mo. Some savings card eligible. |
| Wegovy (brand, with savings card) | $0-$75 | $0-$150 | $0-$300 | Novo Nordisk savings card: $0/mo for eligible commercially insured patients. Eligibility restrictions apply. Not valid for Medicare/Medicaid. |
Projections use provider base prices. Actual costs vary by dose, plan, and eligibility. Kind MD row uses $199/mo starting price.
The data shows a clear pattern. For patients who do not qualify for manufacturer savings programs or who have plans that exclude Wegovy, compounded semaglutide through Kind MD costs roughly 85% less than brand list price over a 12-month treatment course. At the 12-month mark, the savings compared to out-of-pocket brand pricing approach $14,000.
For patients who do qualify for the Novo Nordisk savings card and maintain commercial insurance coverage, brand Wegovy can be the lower-cost option. But that eligibility window is narrow, plan coverage changes annually, and the savings card program itself has income restrictions and geographic limitations. The majority of people starting semaglutide today are paying out of pocket, making the compounded route the financially sensible path.